Unknown OBSERVATIONAL NCT04714307

Neuropsychiatry and Cognition in SCA3/MJD

Neuropsychiatry and Cognition in the Context of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease (SCA3/MJD)

Sponsor: Hospital de Clinicas de Porto Alegre

Conditions MJD Machado-Joseph Disease SCA3 Spinocerebellar Ataxia Type 3

Interventions Activities of Daily Living Clinical Neurological Evaluation Cognitive Testing Emotional Attribution Evaluation Psychiatric Evaluation SCA3/MJD molecular diagnosis

Updated 5 times since 2021 Last updated: Jan 15, 2021 Started: Dec 13, 2019 Primary completion: Feb 1, 2021 Completion: Aug 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04714307, this observational or N/A phase trial focuses on MJD and Machado-Joseph Disease and remains ongoing. Sponsored by Hospital de Clinicas de Porto Alegre, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Sep 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Sep 2023 [monthly]

Recruiting
Feb 2021 — Dec 2021 [monthly]

Recruiting

First recorded

Dec 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital de Clinicas de Porto Alegre

Data source: Hospital de Clinicas de Porto Alegre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Porto Alegre, Brazil